Table 4 Multiple logistic regression analysis of determinants for normotensive blood pressure values
From: Prevalence and determinants of controlled hypertension in a German population cohort
1. Model: Substances | 2. Model: Therapy | |
|---|---|---|
Independent variables | OR 2 (95% CI 3 ) | OR 2 (95% CI 3 ) |
Sex (ref. male) | ||
female | 1.29 (1.03–1.63) (p = 0.030) | 1.33 (1.05–1.67) (p = 0.016) |
Age in years (cont. variable) | ||
0.98 (0.97–0.99) (p = 0.001) | 0.98 (0.97–0.99) (p = 0.001) | |
Risk-comorbidity (ref. no) | ||
yes | 0.39 (0.30–0.52) (p < 0.0001) | 0.40 (0.30–0.53) (p < 0.0001) |
Obesity (ref. no) | ||
yes | 0.60 (0.48–0.76) (p < 0.0001) | 0.62 (0.49–0.77) (p < 0.0001) |
Active smoker 4 (ref. no) | ||
yes | 0.97 (0.73–1.30) (p = 0.845) | 0.97 (0.73–1.30) (p = 0.839) |
Household size (ref. > 1 pers.) | ||
1 person | 1.19 (0.91–1.57) (p = 0.208) | 1.19 (0.91–1.57) (p = 0.206) |
Antihypertensive therapy(ref. no) | ||
mono therapy | - | 0.93 (0.69–1.26) (p = 0.650) |
combination therapy | - | 1.54 (1.16–2.05) (p = 0.003) |
Beta blocker (ref. no) | ||
yes | 1.28 (1.01–1.64) (p = 0.044) | - |
ACE-inhibitors (ref. no) | ||
yes | 1.04 (0.78–1.38) (p = 0.792) | - |
Diuretics (ref. no) | ||
yes | 1.32 (0.95–1.84) (p = 0.097) | - |
Calcium channel blocker (ref. no) | ||
yes | 1.03 (0.76–1.40) (p = 0.841) | - |
Angiotensin II receptor antag. (ref. no) | ||
yes | 1.13 (0.76–1.67) (p = 0.546) | - |
Antiadrenergic substances 5 (ref. no) | ||
yes | 1.16 (0.54–2.48) (p = 0.698) | - |